EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, GenMark Diagnostics's enterprise value is $1,728.2 Mil.
GenMark Diagnostics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $171.6 Mil. Therefore, GenMark Diagnostics's EV-to-Revenue for today is 10.07.
The historical rank and industry rank for GenMark Diagnostics's EV-to-Revenue or its related term are showing as below:
GNMK'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.84 Med: 5.55 Max: 9.87
Current: 10.07
During the past 13 years, the highest EV-to-Revenue of GenMark Diagnostics was 9.87. The lowest was 2.84. And the median was 5.55.
GNMK's EV-to-Revenue is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 3.04
vs GNMK: 10.07
The historical data trend for GenMark Diagnostics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of GenMark Diagnostics's EV-to-Revenue
For the Medical Devices subindustry, GenMark Diagnostics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GenMark Diagnostics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GenMark Diagnostics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where GenMark Diagnostics's EV-to-Revenue falls into.
GenMark Diagnostics's current Enterprise Value is $1,728.2 Mil.
GenMark Diagnostics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $171.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenMark Diagnostics's share price for today is $24.04.
GenMark Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GenMark Diagnostics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of GenMark Diagnostics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
GenMark Diagnostics (GenMark Diagnostics) Business Description
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its operations and assets are in the United States of America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GNMK has been successfully added to your 